Edgar Samaniego speaking at last year’s SVIN meeting

Ahead of the 2025 edition of the Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, Orlando, USA), programme chair Edgar Samaniego (University of Iowa, Iowa City, USA) outlines what attendees can expect from this year’s programme.

As programme chair of the SVIN annual meeting, I’m committed to genuine multidisciplinary collaboration. This year’s theme, ‘Family Together’, highlights how clinicians across specialties and our industry partners work side by side to advance neuroendovascular care and improve patient outcomes. The agenda showcases the strongest science in the field, with plenary sessions, hands-on workshops, and interactive case discussions. Building on last year’s 1,000-plus in-person attendees, this year’s meeting features 36 sessions and 150 faculty.

Two late-breaking trials sessions anchor the scientific agenda on Friday 20 and Saturday 21 November. Highlights include the long-awaited results of CREST-2, comparing medical therapy, endovascular stenting and carotid endarterectomy for asymptomatic carotid stenosis; the Japanese TG-dilator study evaluating a novel endovascular device for intracranial atherosclerosis; and new data on transvascular drainage of subdural haematomas. In all, 14 late-breaking studies will be presented, underscoring SVIN’s commitment to timely, practice-shaping evidence.

Innovation takes centre stage in a special Physician Innovators session, featuring clinicians who have translated bedside insights into platforms that have reshaped the field: Osama Zaidat (Toledo, USA) on intrasaccular flow diversion, Arani Bose (New York, USA) on the treatment of acute ischaemic stroke, Ajay Wakhloo (Boston, USA) on flow diversion, and Adnan Siddiqui (Buffalo, USA) on the Jacobs Institute’s translational ecosystem. A companion session, Design of Clinical Trials for Endovascular Therapy, convenes Gregory Albers (Stanford, USA), Raul Nogueira (Pittsburgh, USA), Jens Fiehler (Hamburg Germany) and Mayank Goyal (Calgary, Canada) to dissect endpoints, enrolment, and real-world trial execution—an essential primer for investigators who would like to better understand clinical trial design.

Education runs deep across 27 sessions and five workshops. In partnership with Stroke Live Course (SLICE), SVIN will deliver two full days of hands-on training, with international experts guiding physicians at all levels through challenging scenarios, bailout strategies, and workflow optimisation. The Advances in Pre-Hospital Care workshop, organised by Brijesh Mehta (Hollywood, USA), revisits triage, routing and prehospital-hospital integration to compress time-to-treatment across systems of care.

Scientific participation is at an all-time high: more than 500 submissions were distilled into 36 oral platform presentations and 120 moderated posters, with accepted work to be published in the Stroke: Vascular and Interventional Neurology (SVIN) journal. Complementing the podium programme, SVINnovation returns with US$150,000 in awards and mentorship for clinician-led startups, plus a new entrepreneurship workshop covering the fundamentals of company building.

The joint session with the World Stroke Organization (WSO), Mission Thrombectomy and SVIN will showcase global experts, and highlight how socioeconomic factors shape endovascular practice worldwide. Speakers will share solutions to technical and logistical barriers in caring for patients with neuroendovascular conditions.

Collaborative sessions broaden the lens. A joint programme with ‘BRAIN’ examines neutrophil extracellular traps, while a session with ‘iCure’ features prerecorded live cases debated by experts. With premier science, world-class faculty, and an emphasis on mentorship and community, SVIN Orlando promises a dynamic forum for learning and networking.  

We’ve carefully curated this programme and look forward to seeing you there. Visit the SVIN website for full details and registration.